SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-037078
Filing Date
2021-07-15
Accepted
2021-07-15 16:41:57
Documents
6
Period of Report
2021-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea144282-8k_inmunebioinc.htm 8-K 38717
2 OPINION OF SICHENZIA ROSS FERENCE LLP ea144282ex5-1_inmunebioinc.htm EX-5.1 11600
3 FORM OF SECURITIES PURCHASE AGREEMENT ea144282ex10-1_inmunebioinc.htm EX-10.1 202469
4 FORM OF PLACEMENT AGENCY AGREEMENT ea144282ex10-2_inmunebioinc.htm EX-10.2 46237
5 PRESS RELEASE ea144282ex99-1_inmunebioinc.htm EX-99.1 9596
6 GRAPHIC ex5-1_001.jpg GRAPHIC 5806
  Complete submission text file 0001213900-21-037078.txt   317934
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 211093086
SIC: 2836 Biological Products, (No Diagnostic Substances)